OMNICOMM SYSTEMS, INC. (OTCMKTS:OMCM) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 01, 2017 Cornelis Wit was named Executive Chairman for OmniComm Systems, Inc. He has been a member of the company’s Board of Directors since November 1999, and served as the Company’s Chief Executive Officer from June 2002 until June 1, 2017.
Stephen Johnson was named Chief Executive Officer and President on June 1, 2017. Mr. Johnson served as the Company’s Chief Operating Officer and President from June 2010 until June 01, 2017. Previously, he served as COO and executive vice president of business development. Mr. Johnson joined OmniComm as the senior vice president of business development in 2006. Prior to joining OmniComm, he spent seven years managing business development for the Oracle Clinical Applications group. He has more than 20 years of industry experience specific to clinical trials and electronic data capture (EDC), having held various positions of increasing responsibility for Oracle, PHT Corp., Clinical Data Solution and Pfizer Pharmaceuticals.
Also on June 1, 2017 Randall Smith, OmniComm’s founder, Chairman of the Board and Chief Technology Officer was named the Company’s Executive Vice Chairman. Mr. Smith has been an executive officer and member of OmniComm’s Board of Directors since 1997. He served as president and CTO from May 1997 until August 2000, and thereafter as Chairman and CTO until June 1, 2017.
Keith Howells was named the Company’s Chief Technology Officer on June 1, 2017. Mr. Howells joined OmniComm in January 2011, with responsibility for the development and innovation of the company’s products. Prior to being named Chief Technology Officer he served as the Senior Vice President of Development. Mr. Howells has more than 20 years of experience in designing, building and implementing clinical research applications, including five years as the head of development for Oracle’s pharmaceutical application suite and five years as the head of development for Medidata Solutions
John Fontenault was named the Company’s Chief Operating Officer on June 1, 2017. He served as our Senior Vice President of Operations from October 2014 until June 2017. A clinical data operations and data systems executive, he brings over 24 years of pharmaceutical industry experience. Prior to joining OmniComm, Mr. Fontenault was Vice President, Operations at ER Squared, providing strategic eClinical business process and technology change management and adoption services to large and small sized sponsors and CROs. Prior to ER Squared, Mr. Fontenault was Executive Director and Global Head of Clinical Data Management and Technology at Kendle International (INC Research).
Kuno van der Post was named the Company’s Chief Commercial Officer on June 1, 2017. He served as the Company’s Senior Vice President of Business Development from June 2013 until June 2017. He has been working in both the preclinical and clinical development arena for over 14 years. Prior to joining OmniComm, he worked for Oracle’s Health Sciences Global Business Unit as well as Medidata Solutions. He obtained his PhD from the University of Liverpool (UK) and his Master of Science from Salford University (UK).
There are no family relationships between any of these officers and any other director or executive officer of the Company. There are no understandings or arrangements between any of the officers and any other person to which the officer was appointed to their new role. There are no unreported related-party transactions between the Company and any of the officers.
About OMNICOMM SYSTEMS, INC. (OTCMKTS:OMCM)
OmniComm Systems, Inc. is engaged in providing Web-based electronic data capture (EDC) and eClinical (eClinical) software and services that manage the clinical research process. The Company’s EDC and eClinical software and service offerings (eClinical Products or eClinical Solutions) consist of TrialMaster, TrialOne, Promasys, and eClinical Suite. Its eClinical Products allows clinical trial sponsors and investigative sites to collect, validate, transmit and analyze clinical study data. Its eClinical Products are designed to offer clinical trial sponsors the ability to conduct clinical trials under multiple platforms. It also provides business process consulting services that focus on integrating EDC, and an array of eClinical Solutions and processes into the clinical trial process. The Company operates through the delivery of EDC Software and services to clinical trial sponsors segment. Its services include hosting solutions, consulting services, customer support and training.
